Effect of Severe Neutropenia Caused by S-1 Adjuvant Chemotherapy on Pancreatic Cancer Prognosis
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b24-00602 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Yusuke Noguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobicho, Kamanza-dori Marutamachi-agaru, Kamigyo-ku, Kyoto 602-8026, Japan. Hauptthemen laut MEDLINE: Tegafur, Oxonic Acid, Neutropenia, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobicho, Kamanza-dori Marutamachi-agaru, Kamigyo-ku, Kyoto 602-8026, Japan.
- Laboratory of Pharmacoepidemiology, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan.
Zitieren
APA
Noguchi, Y., Inose, R., Ohtsubo, T., Kobayashi, D., Kato, Y., Muraki, Y., & Tomogane, K. (2025). Effect of Severe Neutropenia Caused by S-1 Adjuvant Chemotherapy on Pancreatic Cancer Prognosis. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00602
Vancouver
Noguchi Y, Inose R, Ohtsubo T, Kobayashi D, Kato Y, Muraki Y, et al. Effect of Severe Neutropenia Caused by S-1 Adjuvant Chemotherapy on Pancreatic Cancer Prognosis. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00602
BibTeX
@article{Noguchi2025,
author = {Noguchi, Yusuke and Inose, Ryo and Ohtsubo, Tatsuya and Kobayashi, Daisuke and Kato, Yoshitaka and Muraki, Yuichi and Tomogane, Kanji},
title = {Effect of Severe Neutropenia Caused by S-1 Adjuvant Chemotherapy on Pancreatic Cancer Prognosis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b24-00602}
}
EUVIMED